Executive Director, Global Medical Operations

Role: Executive Director of Global MEG Operations, leading the design and scaling of BMS's medical evidence generation operations across multiple therapeutic areas including oncology, hematology, immunology, cardiovascular, and neuroscience. Responsibilities: build and optimize a purpose-built medical study operational model distinct from drug development, oversee organizational structure, define operational frameworks for various study modalities (interventional, observational, externally sponsored), and ensure compliance with regulations like GCP and ICH. Provide strategic leadership on study lifecycle management, vendor oversight, and operational excellence, while partnering with senior leadership to align operational strategies with portfolio needs. Qualifications: 12+ years in pharma/biotech with significant experience in clinical and medical study operations, proven success in building operational organizations from scratch, deep understanding of global regulatory standards, and cross-therapeutic portfolio experience. Skills: strong leadership, organizational design, stakeholder influence, and expertise in complex, matrixed environments. High-Value: focus on medical evidence generation, enterprise-wide scope, multi-therapy portfolio, and building scalable, flexible operational models tailored for real-world and observational studies. Work Setup: not explicitly specified; likely hybrid or remote with global scope.